Fondazione Policlinico Universitario Agostino Gemelli, IRCCS — Roma, RM

Public research footprint of Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, compiled from the ClinicalTrials.gov public registry.

570

Registered studies

378

Active

215

Recruiting now

112

Completed

Stopped or withdrawn

Most-studied conditions

Measles-Mumps-Rubella+Chickenpox Vaccine · Carcinoid Tumor of Ileum · HR Low-Positive/HER2-Negative Breast Neoplasms · Non-small Cell Lung Cancer (NSCLC)

Recently updated registry entries

NCT05889182 — A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in… (Recruiting)
NCT06880744 — A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to… (Active Not Recruiting)
NCT07746024 — Advancing Risk Stratification in Endometrial Cancer (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fondazione Policlinico Universitario Agostino Gemelli, IRCCS?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.